SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Q1 Trading Update

18 Apr 2019 07:00

RNS Number : 5559W
Rentokil Initial PLC
18 April 2019
 

 

RENTOKIL INITIAL PLC (RTO)

FIRST QUARTER TRADING UPDATE

18 April 2019

 

(£m)

 

Q1 2019

Growth

 

 

AER

AER

CER

Ongoing Revenue1

 

603.6

10.6%

8.9%

Revenue

 

607.4

10.3%

8.6%

 

Overview

Trading has started well across our businesses in Q1 with Ongoing Revenue1 increasing by 8.9%, of which 4.0% was Organic Revenue2 growth (Q1 2018: 3.2%, FY 2018: 3.7%) and 4.9% was from acquisitions.

Ongoing Revenue in Pest Control grew by 12.0%, 5.0% Organic (Q1 2018: 4.7%), with good performances being delivered across both Growth and Emerging markets, which rose by 12.1% and 11.5% respectively. Hygiene has made a very positive start to the year, with Ongoing Revenue growth of 7.2% and Organic Revenue growth of 4.3% (Q1 2018: 1.8%). Ongoing Revenue in our Protect & Enhance markets was in line with Q1 2018.

M&A

​We signed eight acquisitions in Q1, four in Pest Control (primarily in North America and Latin America) and four in Hygiene, with combined annualised revenues of c. £29m in the year prior to purchase. We are encouraged about our prospects for further M&A this year and our pipeline of value-enhancing opportunities is strong. Our guidance for M&A spend in 2019 remains in the range of £200m to £250m.  

Pension Scheme and Funding

In December 2018 the Company reached agreement for a bulk annuity insurance 'buy-in' for its UK Defined Benefit Pension scheme ("the Scheme") in contemplation of a full 'buy-out' which is expected to complete in early 2020. Good progress towards buy-out is being made and we now anticipate a pre-tax cash surplus of c. £40m will be returned to the Company on completion.

Ahead of the refinancing of our €500m bond maturing in September this year, we are intending to hold a non-deal, bond investor education roadshow in London, France, Germany, the Netherlands, Nordics and Asia. We will release further details in due course.

Commenting on today's announcement Andy Ransom, Chief Executive, said:

"We have had a good start to 2019 and I'm pleased with our performance in the first three months of this year. I am confident of another year of successful growth for the Company, in line with market expectations."

 

Enquiries:

 

Investors / Analysts:

Katharine Rycroft

Rentokil Initial plc

07811 270734

 

 

 

 

Media:

Malcolm Padley

Rentokil Initial plc

07788 978199

 

 

 

 

1Ongoing Revenue represents the performance of the continuing operations of the Group (including acquisitions) after removing the effect of disposed or closed businesses.

 

2Organic Revenue represents the growth in Ongoing Revenue excluding the effect of businesses acquired during the year. Acquired businesses are included in organic measures in the year following acquisition, and the comparative period is adjusted to include an estimated full year performance for growth calculations.

 

AER - actual exchange rates; CER - constant 2018 exchange rates

 

This announcement contains statements that are, or may be, forward-looking regarding the Group's financial position and results, business strategy, plans and objectives. Such statements involve risk and uncertainty because they relate to future events and circumstances and there are accordingly a number of factors which might cause actual results and performance to differ materially from those expressed or implied by such statements. Forward-looking statements speak only as of the date they are made and no representation or warranty, whether expressed or implied, is given in relation to them, including as to their completeness or accuracy or the basis on which they were prepared. Other than in accordance with the Company's legal or regulatory obligations (including under the Listing Rules and the Disclosure Guidance and Transparency Rules), the Company does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise. Information contained in this announcement relating to the Company or its share price, or the yield on its shares, should not be relied upon as an indicator of future performance. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTZMGMDRNMGLZM
Date   Source Headline
6th Oct 20051:05 pmRNSRule 8.3- Rentokil Initial
6th Oct 200512:51 pmRNSRule 8.3- Rentokil
6th Oct 200512:00 pmRNSRule 8.3- Rentokil Init PLC
6th Oct 200511:43 amRNSEPT Disclosure
6th Oct 200510:49 amRNSRule 8.3-Rentokil Initial Plc
5th Oct 20054:17 pmRNSEPT Disclosure - Amendment
5th Oct 20051:18 pmRNSRule 8.3- Rentokil Initial
5th Oct 200511:39 amRNSEPT Disclosure
5th Oct 200511:20 amRNSRule 8.3- Rentokil Init PLC
5th Oct 200511:04 amRNSRule 8.3-Rentokil Initial PLC
5th Oct 20059:55 amRNSRule 8.3-Rentokil Initial PLC
4th Oct 20056:22 pmRNSEPT Disclosure - Amendment
3rd Oct 20056:28 pmRNSEPT Disclosure - Amendment
3rd Oct 20053:43 pmRNSRule 8.3-Rentokil Initial Plc
3rd Oct 20051:01 pmRNSEPT Disclosure
3rd Oct 200512:06 pmRNSEPT Disclosure - CFD
3rd Oct 200512:03 pmRNSRule 8.3-Rentokil Initial Plc
3rd Oct 200511:06 amRNSRule 8.3- Rentokil Init PLC
30th Sep 20052:00 pmRNSHolding(s) in Company
30th Sep 20051:29 pmRNSRule 8.3-Rentokil Initial PLC
30th Sep 200512:46 pmRNSRule 8.3-Rentokil Initial PLC
30th Sep 200511:49 amRNSRule 8.3- Rentokil
30th Sep 200511:45 amRNSEPT Disclosure - CFD
30th Sep 200511:28 amRNSEPT Disclosure
30th Sep 200510:19 amRNSRule 8.3- Rentokil Initial
29th Sep 200512:21 pmRNSEPT Disclosure
29th Sep 200511:55 amRNSRule 8.3-Rentokil Initial PLC
29th Sep 200511:48 amRNSRule 8.3- Rentokil
29th Sep 200511:22 amRNSRule 8.3-Rentokil Initial Plc
29th Sep 200511:06 amRNSRule 8.3- Rentokil Initial
29th Sep 200510:37 amRNSInitial Style Conferences
29th Sep 200510:13 amRNSRule 8.3- Rentokil Initial
28th Sep 200512:19 pmRNSEPT Disclosure - CFD
28th Sep 200512:03 pmRNSRule 8.3-Rentokil Initial PLC
28th Sep 200512:01 pmRNSEPT Disclosure
28th Sep 200511:23 amRNSRule 8.3- Rentokil Initial PL
28th Sep 200510:30 amRNSRule 8.3- Rentokil Initial
28th Sep 200510:13 amRNSRule 8.3-Rentokil Initial PLC
27th Sep 20055:31 pmRNSEPT Disclosure - Amendment
27th Sep 200512:53 pmRNSEPT Disclosure
27th Sep 200511:35 amRNSRule 8.3- Rentokil Initial
27th Sep 200510:27 amRNSRule 8.3- Rentokil Init PLC
27th Sep 20058:33 amRNSRule 2.10 Announcement
26th Sep 200512:50 pmRNSRule 8.3- (Rentokil Initial)
26th Sep 200512:21 pmRNSEPT Disclosure
26th Sep 200510:40 amRNSRule 8.3- Rentokil Init PLC
26th Sep 200510:25 amRNSRule 8.3- Rentokil Initial
23rd Sep 20053:24 pmRNSEPT Disclosure Amendment
23rd Sep 200512:36 pmRNSEPT Disclosure - CFD
23rd Sep 200512:26 pmRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.